WebbEstablished in 2024 the Western Australian Cardiovascular Research Alliance (WACRA) unites leading heart, stroke and vascular disease researchers from universities and institutes in Western Australia working across the pipeline from fundamental pre-clinical research, epidemiology and public health through to clinical trials. Pre-Clinical Discovery Webb21 maj 2024 · Our Speaker. PROFESOR MARKUS SCHLAICH is the Dobney Chair in Clinical Research at the Dobney Hypertension Centre (a joint venture between RPH Research Foundation, Royal Perth Hospital and The University of Western Australia).. PROFESSOR SCHLAICH is a renal physician and an ESH accredited hypertension specialist with a …
Prof. Markus Schlaich - A:care HCP thailand
WebbCorrespondence to Professor Markus Schlaich, Neurovascular Hypertension & Kidney Disease Laboratory, Baker IDI Heart and Diabetes Institute, 75 Commercial Rd., Melbourne ... Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study ... Webb11 apr. 2024 · Professor Markus Schlaich is the Dobney Chair of Clinical Research at the University of Western Australia. They discuss hypertension control rates in Australia and … chronically slow tub drain
Dual endothelin antagonist aprocitentan for resistant hypertension …
WebbWinthrop Professor Markus Schlaich Dobney Chair in Clinical Research School of Medicine - Royal Perth Hospital Unit The University of Western Australia Level 3, MRF Building, Rear 50 Murray St, Perth WA 6000; Australia Phone: +61 8 9224 0382 Fax: +61 8 9224 0374 e-mail: [email protected] WebbFör 1 dag sedan · Cardiovascular Symposium 2024: rallying together for better heart and blood vessel health Webb8 nov. 2024 · Australian researchers have shown that a novel drug targeting the endothelin pathway is effective in treating resistant hypertension, producing sustained lowering of blood pressure over 48 weeks. The dual endothelin receptor antagonist aprocitentan was investigated in a multicentre phase 3 randomised controlled trial, PRECISION, led by WA … chronically stressed